Home » Emba Gets CE Mark for Hourglass Embolization Device
Emba Gets CE Mark for Hourglass Embolization Device
Emba Medical Limited has received CE Mark approval for its Hourglass Embolization Device, the Dublin-Ireland company announced Wednesday.
The device represents a breakthrough in peripheral embolism devices because it provides precise, secure, over-the-wire delivery and immediate occlusion with a single integrated device, the company claims.
Device co-developer Andrew Cragg says its unique design was created to take advantage of natural hemodynamic forces to provide immediate, stable occlusions.
The Hourglass is a class IIb medical device that will be manufactured in Miramar, Fla. It is not approved for sale in the U.S. — John Bechtel
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May